Bioprocessing Antibody Drug Conjugates in Biopharma: Making Magic Bullets

Article   Mar 28, 2017 | Original Article by Adam Tozer Ph.D

 
Bioprocessing Antibody Drug Conjugates in Biopharma: Making Magic Bullets

ADCs are the next generation of cancer therapies. Credit: Lonza

 
 
 

RELATED ARTICLES

Microfluidic Method Identifies Rare Antibodies with Therapeutic Potential

Article

A novel microfluidic platform, able to rapidly isolate and identify rare antibodies from a vast repertoire of human B cells, has been developed by scientists. This technology could possess the ability to support and enhance the development of novel vaccines and biopharmaceuticals in the future.

READ MORE

Promoting the Use of AI within the Life Sciences Industry

Article

Awareness of Artificial Intelligence (AI), Machine Learning (ML) and Neuro-linguistic Programming (NLP) is ever-increasing, with AI being one of the most talked about technologies across multiple industries. The Pistoia Alliance recently surveyed 374 life science professionals to determine the impact of AI, ML and NLP on the life sciences industry.

READ MORE

Neuroinformatics and The Blue Brain Project

Article

The Blue Brain Project is an attempt to reverse engineer the rodent brain (and ultimately, the human brain) and recreate it at the cellular level inside a computer simulation.

READ MORE

 

Comments | 1 ADD COMMENT

Ana Aitawa | Oct 03, 2017

iHealthcareAnalyst, Inc. - The global antibody drug conjugates market expected to reach US$ 4.6 billion by 2021, growing at CAGR 30.2% over the forecast period 2017-2021, owing to increasing drug prices and rapid approval of new treatments. Visit Antibody Drug Conjugates Market by Marketed Drugs – Adcetris or SGN-35 (Brentuximab vedotin), Kadcyla or T-DM1 (Trastuzumab emtansine), Pipeline Drugs – Rova-T or SC16LD6.5 (Rovalpituzumab tesirine), CDX-011 (Glembatumumab vedotin), Besponsa or CMC-544 (Inotuzumab ozogamicin), IMGN853 (Mirvetuximab soravtansine), SGN-CD33A (Vadastuximab talirine) and Forecast 2017-2021 https://www.ihealthcareanalyst.com/report/antibody-drug-conjugates-market/


Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE